Spectrum Pharma (NASDAQ: SPPI) announced it has entered into a licensing agreement with Hanmi Pharmaceuticals for poziotinib, a drug being ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE